Ligand Pharmaceuticals (LGND) Stock
Ligand Pharmaceuticals (LGND) closed at $308.79 on Nov 13, 2026; its Tenet Score is 40 of 100 against 313 Healthcare peers.
7 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Previous close
- $308.79
- Nov 13, 2026
- Market cap
- $6.2B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- P/E
- 119.8×
- price ÷ earnings
- 52-week range
- 175.89 – 326.63
- low → high · as of close, Nov 13, 2026
- Tenet Score
- 40/100
- Weak · 313 Healthcare peers
Industry: Drugs
Ligand Pharmaceuticals, Inc. scores 40/100. Weak. Strongest on growth, value is the soft spot, trading at 120× earnings versus 313 Healthcare peers.
Tenet Score · vs sector
n=313Factor grades
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ✕ Piotroski F-Score
- ✕ Munger Compounders
- ✕ Magic Formula
- ✕ Graham Defensive
- ✕ Lynch GARP
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 13, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Axsome Therapeutics IncAXSM | 30 | $7.5B |
| Amneal Pharmaceuticals IncAMRX | 38 | $7.4B |
| Oruka Therapeutics Inc.ORKA | 54 | $7.1B |
| Twist Bioscience CorpTWST | 39 | $7.0B |
| Arrowhead Pharmaceuticals Inc.ARWR | 34 | $6.8B |
| Belite Bio IncBLTE | 55 | $6.5B |
| ImmunityBio IncIBRX | 52 | $6.4B |
| PTC Therapeutics IncPTCT | 57 | $5.3B |
| Dianthus Therapeutics IncDNTH | 63 | $5.2B |
| Liquidia CorpLQDA | 54 | $5.1B |
Common questions
What sector and industry is Ligand Pharmaceuticals in?
Ligand Pharmaceuticals is in the Healthcare sector and the Drugs industry.
What is Ligand Pharmaceuticals' Tenet Score?
Ligand Pharmaceuticals' Tenet Score is 40 out of 100, ranked against 313 Healthcare peers as of Nov 13, 2026.




